▁London 10.375
, 4.671875
▁UK 6.25
▁- 5.40234375
▁Can 7.5859375
cer 2.080078125
▁patients 5.56640625
▁and 2.982421875
▁their 2.736328125
▁do 2.6640625
ctors 0.00597381591796875
▁are 3.435546875
▁eager 7.76171875
ly 1.7080078125
▁await 0.6025390625
ing 0.1197509765625
▁new 4.49609375
▁data 3.34765625
▁on 1.294921875
▁British 6.18359375
▁Bi 8.90625
ote 2.458984375
ch 1.0966796875
' 6.30859375
s 0.5029296875
▁anti 8.4609375
- 0.77294921875
can 1.90625
cer 0.016357421875
▁treatment 3.953125
, 3.267578125
▁Mar 10.171875
im 8.7734375
ast 8.109375
at 5.375
▁at 6.7265625
▁the 1.9130859375
▁European 7.125
▁Society 4.34765625
▁for 3.45703125
▁Medical 5.875
▁On 5.67578125
col 1.1103515625
ogy 0.9052734375
▁( 5.14453125
ES 6.515625
MO 0.41943359375
) 0.533203125
▁meeting 9.609375
▁in 2.212890625
▁Madrid 5.80078125
, 1.3076171875
▁Spain 3.44921875
. 2.673828125
<0x0A> 1.36328125
Mar 4.59765625
im 1.1123046875
ast 0.167236328125
at 0.0188140869140625
▁is 2.607421875
▁a 0.7607421875
▁type 5.453125
▁of 0.037994384765625
▁drug 2.720703125
▁called 0.908203125
▁a 0.444091796875
▁matrix 7.36328125
▁metal 0.289794921875
lo 0.0022449493408203125
prote 0.05267333984375
in 0.1328125
ase 0.006622314453125
▁en 5.078125
zym 0.0855712890625
e 0.006076812744140625
▁in 0.320556640625
hib 0.0006995201110839844
itor 0.00475311279296875
, 1.5224609375
▁which 0.77880859375
▁works 2.78125
▁by 0.51318359375
▁blocking 1.560546875
▁an 2.74609375
▁en 0.0814208984375
zym 5.5789947509765625e-05
e 0.002208709716796875
▁that 1.27734375
▁prom 3.98828125
otes 0.00011563301086425781
▁the 1.08203125
▁spread 3.240234375
▁of 0.2200927734375
▁cancer 0.434326171875
▁cells 0.3427734375
. 0.464111328125
▁The 2.015625
▁drug 1.2802734375
▁has 2.255859375
▁been 0.67333984375
▁in 3.390625
▁development 0.95751953125
▁for 0.393310546875
▁over 2.2890625
▁a 1.2548828125
▁de 0.036346435546875
cade 0.00014162063598632812
▁and 1.26953125
▁has 1.3427734375
▁already 3.03125
▁under 4.05078125
g 0.00738525390625
one 0.0002701282501220703
▁several 2.328125
▁clin 0.6416015625
ical 0.0005102157592773438
▁tri 0.2021484375
als 1.811981201171875e-05
. 1.037109375
<0x0A> 0.9306640625
B 4.5078125
rit 0.638671875
ish 0.0111236572265625
▁Bi 0.5361328125
ote 0.0022449493408203125
ch 0.12548828125
▁CE 5.71484375
O 0.002613067626953125
, 1.341796875
▁Jo 6.14453125
anna 1.95703125
▁Hor 7.3046875
ob 2.197265625
in 0.041351318359375
, 0.55810546875
▁said 0.61767578125
: 0.56494140625
▁" 0.199462890625
We 1.12109375
▁are 0.37890625
▁excited 2.361328125
▁to 0.40087890625
▁share 3.53125
▁our 2.005859375
▁latest 1.763671875
▁data 1.724609375
▁at 3.048828125
▁the 0.931640625
▁ES 0.88671875
MO 0.0020771026611328125
▁meeting 0.54248046875
. 1.7021484375
▁Mar 2.69140625
im 0.005802154541015625
ast 0.004901885986328125
at 0.0007166862487792969
▁has 1.060546875
▁the 2.3125
▁potential 0.058319091796875
▁to 0.01132965087890625
▁be 1.296875
▁a 0.591796875
▁game 1.8955078125
- 0.27880859375
ch 0.002349853515625
anger 0.85302734375
▁in 0.83349609375
▁the 0.439697265625
▁field 3.39453125
▁of 0.0689697265625
▁cancer 0.5927734375
▁treatment 0.68017578125
, 1.22265625
▁and 1.1455078125
▁we 0.5830078125
▁are 0.96435546875
▁committed 3.4453125
▁to 0.00438690185546875
▁adv 3.18359375
ancing 0.0013399124145507812
▁research 5.75
▁and 1.1689453125
▁development 0.873046875
▁to 1.5400390625
▁bring 1.3134765625
▁this 0.64599609375
▁drug 2.5
▁to 0.107177734375
▁patients 0.640625
▁in 1.810546875
▁need 0.191650390625
." 0.736328125
<0x0A> 0.0516357421875
The 1.9462890625
▁latest 3.517578125
▁data 0.650390625
▁being 4.46875
▁presented 0.22998046875
▁at 0.478271484375
▁ES 0.82568359375
MO 0.0005011558532714844
▁could 7.84765625
▁be 2.673828125
▁a 1.7080078125
▁major 2.251953125
▁step 1.2197265625
▁forward 0.759765625
▁in 0.50927734375
▁the 0.595703125
▁development 1.091796875
▁of 0.047393798828125
▁Mar 1.046875
im 0.002719879150390625
ast 0.003665924072265625
at 0.0011014938354492188
. 1.3671875
▁The 1.322265625
▁drug 2.125
▁is 1.5107421875
▁being 2.236328125
▁tested 1.5244140625
▁in 0.36376953125
▁combination 2.67578125
▁with 0.05316162109375
▁other 1.623046875
▁cancer 1.4150390625
▁treat 0.93359375
ments 2.7894973754882812e-05
, 0.9912109375
▁and 1.548828125
▁the 1.76171875
▁new 3.498046875
▁data 0.52490234375
▁will 2.771484375
▁reve 6.47265625
al 0.00014925003051757812
▁how 1.736328125
▁well 1.181640625
▁it 1.0166015625
▁has 5.4375
▁performed 2.31640625
▁in 0.71484375
▁these 2.52734375
▁studies 3.404296875
. 0.1976318359375
<0x0A> 0.420166015625
Anal 7.1171875
yst 0.44580078125
s 0.099365234375
▁have 2.42578125
▁long 5.06640625
▁been 1.265625
▁b 2.912109375
ull 0.0014190673828125
ish 0.00018477439880371094
▁on 0.20556640625
▁Mar 1.2275390625
im 0.004390716552734375
ast 0.00460052490234375
at 0.000965118408203125
, 0.7890625
▁cit 4.21875
ing 5.650520324707031e-05
▁its 0.8154296875
▁prom 3.759765625
ising 0.00032210350036621094
▁clin 1.888671875
ical 0.00043487548828125
▁trial 1.2646484375
▁results 0.401611328125
▁and 0.6748046875
▁potential 2.017578125
▁to 1.0517578125
▁address 3.2265625
▁a 0.69921875
▁significant 1.3369140625
▁un 0.421142578125
met 0.00241851806640625
▁need 0.77490234375
▁in 0.427001953125
▁the 1.2294921875
▁cancer 0.87646484375
▁treatment 0.25927734375
▁landscape 3.86328125
. 0.0229339599609375
▁But 5.13671875
▁the 1.5048828125
▁drug 1.357421875
▁has 1.294921875
▁yet 1.6318359375
▁to 0.00029277801513671875
▁receive 1.16796875
▁regul 1.84765625
atory 9.5367431640625e-05
▁appro 0.03338623046875
val 1.33514404296875e-05
, 1.0634765625
▁and 0.8583984375
▁there 2.583984375
▁are 1.1533203125
▁some 3.265625
▁concerns 2.041015625
▁about 0.7158203125
▁its 0.884765625
▁safety 1.5263671875
▁profile 0.74169921875
. 0.401611328125
<0x0A> 0.29931640625
One 4.33203125
▁of 1.47265625
▁the 0.0731201171875
▁key 2.873046875
▁issues 2.60546875
▁with 1.501953125
▁Mar 0.27490234375
im 0.0015430450439453125
ast 0.003833770751953125
at 0.0005869865417480469
▁is 0.10400390625
▁its 0.92236328125
▁potential 1.0615234375
▁to 0.449951171875
▁cause 0.364990234375
▁li 3.513671875
ver 0.00203704833984375
▁to 0.931640625
x 0.039093017578125
icity 0.00011277198791503906
. 0.955078125
▁Some 4.4765625
▁patients 0.828125
▁in 4.71875
▁earlier 4.0
▁clin 1.02734375
ical 8.189678192138672e-05
▁tri 0.09234619140625
als 2.9802322387695312e-06
▁experienced 1.2392578125
▁elev 4.0078125
ated 0.10284423828125
▁li 0.14892578125
ver 0.00037097930908203125
▁en 0.1424560546875
zym 0.0001195669174194336
es 0.285400390625
, 0.7431640625
▁and 1.345703125
▁there 2.224609375
▁is 1.4150390625
▁a 1.330078125
▁worry 7.5390625
▁that 0.045318603515625
▁long 6.515625
- 0.036590576171875
term 0.0016374588012695312
▁use 0.273681640625
▁of 0.324462890625
▁the 0.1697998046875
▁drug 0.019561767578125
▁could 0.2822265625
▁lead 0.68603515625
▁to 0.0011358261108398438
▁li 1.203125
ver 8.153915405273438e-05
▁damage 0.6494140625
. 0.251953125
<0x0A> 0.420654296875
However 2.92578125
, 0.001720428466796875
▁British 3.322265625
▁Bi 0.006061553955078125
ote 0.00027823448181152344
ch 0.01081085205078125
▁has 1.041015625
▁worked 4.74609375
▁to 1.6923828125
▁address 0.525390625
▁these 0.64794921875
▁concerns 0.08380126953125
, 1.1982421875
▁and 0.310302734375
▁the 1.1748046875
▁company 0.72900390625
▁says 2.73828125
▁that 0.919921875
▁the 1.4765625
▁latest 2.27734375
▁data 0.2430419921875
▁shows 2.07421875
▁no 3.205078125
▁signs 2.419921875
▁of 0.0148773193359375
▁li 0.220947265625
ver 0.00011146068572998047
▁to 0.3642578125
x 0.00121307373046875
icity 0.000335693359375
. 1.025390625
▁The 1.5341796875
▁data 3.080078125
▁being 4.04296875
▁presented 0.051788330078125
▁at 0.0882568359375
▁ES 0.10693359375
MO 0.00017702579498291016
▁will 2.62109375
▁provide 2.28515625
▁further 1.3486328125
▁insight 0.9931640625
▁into 0.041046142578125
▁the 0.51953125
▁safety 1.177734375
▁and 2.103515625
▁effic 0.34033203125
acy 9.775161743164062e-06
▁of 0.046356201171875
▁the 1.2333984375
▁drug 0.0161590576171875
. 1.6474609375
<0x0A> 0.068603515625
If 3.447265625
▁Mar 1.6494140625
im 0.0010061264038085938
ast 0.0019893646240234375
at 0.00022423267364501953
▁is 1.189453125
▁ultimately 4.8203125
▁approved 0.08502197265625
, 1.40625
▁it 0.10601806640625
▁could 0.2498779296875
▁be 1.1533203125
▁a 0.06231689453125
▁game 0.66943359375
- 0.076904296875
ch 0.000774383544921875
anger 0.10809326171875
▁in 0.52978515625
▁the 0.09088134765625
▁cancer 2.98046875
▁treatment 0.03509521484375
▁market 4.03515625
. 0.1956787109375
▁The 0.400146484375
▁drug 0.0933837890625
▁is 1.546875
▁being 1.603515625
▁tested 0.55712890625
▁in 0.041778564453125
▁a 2.884765625
▁range 2.5546875
▁of 0.00033283233642578125
▁can 2.044921875
cers 4.2438507080078125e-05
, 0.10235595703125
▁including 0.61328125
▁lung 2.224609375
▁cancer 0.93701171875
, 0.1441650390625
▁pan 2.6484375
cre 0.00011873245239257812
atic 0.0191497802734375
▁cancer 0.00981903076171875
, 0.125244140625
▁and 0.72607421875
▁certain 5.5390625
▁types 0.2259521484375
▁of 0.0002117156982421875
▁le 1.6357421875
uk 0.2008056640625
emia 0.004390716552734375
. 0.247802734375
<0x0A> 1.1572265625
Acc 5.9921875
ording 0.00467681884765625
▁to 0.002971649169921875
▁the 1.3125
▁American 2.787109375
▁Can 0.064453125
cer 0.000362396240234375
▁Society 0.005802154541015625
, 0.07733154296875
▁there 2.421875
▁are 1.21484375
▁approximately 2.296875
▁ 0.0211334228515625
1 0.1669921875
. 0.63818359375
8 2.783203125
▁million 0.028472900390625
▁new 0.322509765625
▁cancer 0.7734375
▁cases 0.04986572265625
▁diagn 0.7734375
osed 0.00033283233642578125
▁each 0.83837890625
▁year 6.794929504394531e-05
▁in 0.378173828125
▁the 0.006641387939453125
▁United 0.335205078125
▁States 0.0012350082397460938
▁alone 1.9501953125
. 0.152587890625
▁The 2.37890625
▁global 3.3671875
▁cancer 0.431884765625
▁treatment 1.4111328125
▁market 0.0631103515625
▁is 0.260009765625
▁project 3.37109375
ed 0.0003445148468017578
▁to 0.000545501708984375
▁reach 0.4638671875
▁$ 0.347900390625
2 1.8134765625
3 2.3828125
7 2.44140625
. 0.70703125
8 2.205078125
▁billion 0.334716796875
▁by 0.053009033203125
▁ 0.02581787109375
2 1.1324882507324219e-05
0 1.1444091796875e-05
2 0.296142578125
6 1.3583984375
, 0.2841796875
▁driven 3.2890625
▁by 0.12237548828125
▁an 2.087890625
▁ag 1.8798828125
ing 0.0009570121765136719
▁population 0.0633544921875
▁and 0.367919921875
▁increasing 1.4267578125
▁rates 3.07421875
▁of 0.0010614395141601562
▁cancer 0.32861328125
▁diagn 1.6337890625
oses 1.43359375
. 0.1954345703125
<0x0A> 0.160400390625
Can 5.58203125
cer 0.103515625
▁treatment 1.6962890625
▁options 3.455078125
▁have 2.6171875
▁come 2.630859375
▁a 0.0204315185546875
▁long 0.0032901763916015625
▁way 0.0009822845458984375
▁in 0.52294921875
▁recent 0.304443359375
▁years 0.1385498046875
, 0.284423828125
▁with 0.978515625
▁the 2.2265625
▁development 1.0107421875
▁of 0.0210418701171875
▁new 0.806640625
▁imm 5.88671875
un 0.050079345703125
other 0.001071929931640625
ap 0.5712890625
ies 0.00010859966278076172
▁and 0.68408203125
▁target 0.4345703125
ed 0.0013189315795898438
▁ther 1.1845703125
ap 0.0084228515625
ies 1.9073486328125e-06
. 0.8505859375
▁However 1.466796875
, 0.0008325576782226562
▁there 0.71630859375
▁is 0.6240234375
▁still 0.07373046875
▁a 0.431396484375
▁significant 1.60546875
▁need 1.6376953125
▁for 0.0545654296875
▁new 1.0859375
▁treat 1.4951171875
ments 5.602836608886719e-06
▁that 1.07421875
▁can 0.7763671875
▁address 1.3349609375
▁the 1.0908203125
▁spread 9.96875
▁of 0.051727294921875
▁cancer 0.060394287109375
▁cells 0.28515625
▁and 1.01953125
▁improve 1.173828125
▁overall 3.453125
▁surv 0.70947265625
ival 0.0012531280517578125
▁rates 0.2191162109375
. 0.1387939453125
<0x0A> 0.30615234375
Mar 0.611328125
im 0.0021533966064453125
ast 0.002079010009765625
at 0.0001653432846069336
▁represents 4.6953125
▁a 0.487548828125
▁potential 1.6259765625
▁break 1.5576171875
through 0.00045800209045410156
▁in 0.127197265625
▁this 0.448974609375
▁regard 1.8974609375
, 0.311767578125
▁and 1.0380859375
▁the 1.00390625
▁data 1.927734375
▁being 0.255126953125
▁presented 0.01218414306640625
▁at 0.00746917724609375
▁ES 0.066162109375
MO 8.952617645263672e-05
▁could 0.441650390625
▁be 1.0654296875
▁a 0.198974609375
▁major 0.369873046875
▁catal 6.82421875
yst 0.0002758502960205078
▁for 0.18408203125
▁the 0.35107421875
▁drug 1.0849609375
' 0.1539306640625
s 0.0002396106719970703
▁development 0.90185546875
. 0.279541015625
<0x0A> 1.4677734375
With 4.42578125
▁so 3.98828125
▁much 0.42431640625
▁r 3.28515625
iding 0.0001481771469116211
▁on 0.0008153915405273438
▁the 0.69287109375
▁success 0.576171875
▁of 0.0029926300048828125
▁Mar 0.287353515625
im 0.0005965232849121094
ast 0.0015506744384765625
at 0.00018775463104248047
, 0.0404052734375
▁anal 2.826171875
yst 3.5643577575683594e-05
s 0.0008950233459472656
▁are 0.89306640625
▁eager 2.291015625
ly 0.72900390625
▁await 0.294921875
ing 0.0003669261932373047
▁the 0.374755859375
▁latest 0.7763671875
▁data 0.189453125
▁from 1.3095703125
▁the 0.40869140625
▁ES 0.81103515625
MO 0.0004031658172607422
▁meeting 0.10150146484375
. 0.29443359375
▁If 2.083984375
▁the 0.2230224609375
▁drug 0.75927734375
▁shows 2.65625
▁positive 2.853515625
▁results 0.045074462890625
▁in 3.5390625
▁the 1.8388671875
▁tri 2.732421875
als 1.9788742065429688e-05
, 0.463134765625
▁it 0.139404296875
▁could 0.0479736328125
▁be 0.77001953125
▁a 0.05169677734375
▁major 0.955078125
▁step 1.1533203125
▁forward 0.067626953125
▁in 0.32177734375
▁the 0.181640625
▁fight 2.134765625
▁against 0.00385284423828125
▁cancer 0.00817108154296875
, 3.48828125
▁and 0.30810546875
▁a 2.337890625
▁major 1.9609375
▁win 3.66796875
▁for 0.0028591156005859375
▁British 0.1492919921875
▁Bi 0.0035152435302734375
ote 0.00011622905731201172
ch 0.0032482147216796875
. 0.1636962890625
